“The outlook revision to negative reflects sharply weaker fiscal 2016 year-to-date performance through the nine-month unaudited period ended Sept. 30, 2016, combined with a meaningful decline in unrestricted reserves,” said S&P analyst Martin Arrick.
S&P also affirmed the “BBB” rating on DHHA’s series 2007A, 2007B, 2009A, 2010, 2014A and 2014B bonds. The rating affirmation reflects S&P’s view of DHHA’s strong enterprise profile and adequate financial profile.
More articles on healthcare finance:
MACPAC calls for extending CHIP federal funding through FY 2022
5 most-read finance stories: Week of Dec. 12-16
CMS adds advanced APM opportunities under MACRA
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
